Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Liu

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
JAMA Dermatology|March 9, 2022
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical TrialsEric L Simpson, Kim A Papp, Andrew Blauvelt, et al.
Science (New York, N.Y.)|December 17, 2016
CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cellsS John Liu, Max A Horlbeck, Seung Woo Cho, et al.
Science (New York, N.Y.)|December 9, 2017
Spatiotemporal gene expression trajectories reveal developmental hierarchies of the human cortexTomasz J Nowakowski, Aparna Bhaduri, Alex A Pollen, et al.
Cell|May 8, 2018
Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary ElementSeung Woo Cho, Jin Xu, Ruping Sun, et al.
Nature Genetics|May 17, 2024
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolutionCalixto-Hope G Lucas, Kanish Mirchia, Kyounghee Seo, et al.
Heliyon|March 23, 2023
Obligate role for Rock1 and Rock2 in adult stem cell viability and functionArivazhagan Sambandam, Elaine Storm, Helen Tauc, et al.
Lancet (London, England)|May 23, 2021
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trialsEmma Guttman-Yassky, Henrique D Teixeira, Eric L Simpson, et al.
Frontiers in Genetics|June 4, 2019
Genome to Phenome: Improving Animal Health, Production, and Well-Being - A New USDA Blueprint for Animal Genome Research 2018-2027Caird Rexroad, Jeffrey Vallet, Lakshmi Kumar Matukumalli, et al.
Cell Reports|February 6, 2020
Multiplatform Molecular Profiling Reveals Epigenomic Intratumor Heterogeneity in EpendymomaS John Liu, Stephen T Magill, Harish N Vasudevan, et al.
Genome Biology|April 3, 2020
CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in gliomaS John Liu, Martina Malatesta, Brian V Lien, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
JAMA Dermatology|March 9, 2022
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical TrialsEric L Simpson, Kim A Papp, Andrew Blauvelt, et al.
Science (New York, N.Y.)|December 17, 2016
CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cellsS John Liu, Max A Horlbeck, Seung Woo Cho, et al.
Science (New York, N.Y.)|December 9, 2017
Spatiotemporal gene expression trajectories reveal developmental hierarchies of the human cortexTomasz J Nowakowski, Aparna Bhaduri, Alex A Pollen, et al.
Cell|May 8, 2018
Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary ElementSeung Woo Cho, Jin Xu, Ruping Sun, et al.
Nature Genetics|May 17, 2024
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolutionCalixto-Hope G Lucas, Kanish Mirchia, Kyounghee Seo, et al.
Heliyon|March 23, 2023
Obligate role for Rock1 and Rock2 in adult stem cell viability and functionArivazhagan Sambandam, Elaine Storm, Helen Tauc, et al.
Lancet (London, England)|May 23, 2021
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trialsEmma Guttman-Yassky, Henrique D Teixeira, Eric L Simpson, et al.
Frontiers in Genetics|June 4, 2019
Genome to Phenome: Improving Animal Health, Production, and Well-Being - A New USDA Blueprint for Animal Genome Research 2018-2027Caird Rexroad, Jeffrey Vallet, Lakshmi Kumar Matukumalli, et al.
Cell Reports|February 6, 2020
Multiplatform Molecular Profiling Reveals Epigenomic Intratumor Heterogeneity in EpendymomaS John Liu, Stephen T Magill, Harish N Vasudevan, et al.
Genome Biology|April 3, 2020
CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in gliomaS John Liu, Martina Malatesta, Brian V Lien, et al.
Pageof 15